A Study of Rofecoxib in the Treatment of Post-Operative Pain After Total Knee Joint Replacement (0966-259)

NCT00140920 · clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
11
Enrollment
INDUSTRY
Sponsor class

Stopped Recruitment/study discontinued after withdrawal of marketing authorisation. No data entered.

Conditions

Interventions

Sponsor

Merck Sharp & Dohme LLC